Your browser doesn't support javascript.
loading
Perceptions and Attitudes of Patients and Their Family Caregivers on Nebulization Therapy for COPD.
Dumra, Harjit; Khanna, Arjun; Madhukar, Sujeet K; Lopez, Meena; Gogtay, Jaideep.
Afiliación
  • Dumra H; Sparsh, Chest Disease Centre, Navrangpura, Ahmedabad, India.
  • Khanna A; Pulmonary Medicine, Amrita Hospital and Research Institute, Faridabad, Haryana, India.
  • Madhukar SK; Madhukar's Clinic and Lung Hospital, Patna, Bihar, India.
  • Lopez M; Medical Affairs Department, Cipla Ltd, Mumbai, Maharashtra, India.
  • Gogtay J; Medical Affairs Department, Cipla Ltd, Mumbai, Maharashtra, India.
Int J Chron Obstruct Pulmon Dis ; 17: 2277-2288, 2022.
Article en En | MEDLINE | ID: mdl-36133736
ABSTRACT

Purpose:

The aim of the survey was to evaluate attitudes and perceptions toward nebulization therapy for the management of chronic obstructive pulmonary disease (COPD) in Indian population. Patients and

methods:

A cross-sectional, multicenter, quantitative survey was conducted from July to August 2019 among 103 COPD patients [>40 years, either gender, belonging to socio-economic class (SEC) A or SEC B] and their family caregivers. One-on-one interviews were conducted telephonically via an online survey platform (KoBo data collection tool) using a structured questionnaire. Patients receiving home nebulization were included, and the usage of nebulizers, satisfaction, and benefits and concerns with nebulizers were assessed.

Results:

Overall, 47% patients were on handheld inhalers + nebulizer, 54% used nebulizer for >8 weeks, and 27% used nebulizers daily for home maintenance. Majority of the patients (77%) were satisfied with nebulization therapy. Around 70% family caregivers opined that the quality of life of COPD patients improved post-nebulization therapy. The benefits of nebulizers perceived by patients were easier breathing (89%), feeling of well-being (86%), and ease of use (86%), while family caregivers reported reduced hospitalization (76%) and easier breathing (75%). Among those with prior experience with inhalers, 72% felt nebulizers gave long-term relief, while 65% perceived having immediate relief compared to inhaler. Overall, 61% opined that benefits with nebulizers outweighed the inconvenience associated with its use. Key concerns regarding nebulizers cited by patients were time-consuming procedure (50%), feeling of dependency (49%), and social embarrassment (48%), while family caregivers highlighted social embarrassment (45%) and multiple daily use (45%) as major concerns. Majority of the patients (73%) were compliant with their recommended frequency of the nebulizer.

Conclusion:

This first-of-its-kind survey highlights that the majority of patients and family caregivers were satisfied with nebulizers and reported improvements in symptoms and reduced hospitalizations with nebulizer therapy. The patients preferred nebulized therapy to inhalers.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Int J Chron Obstruct Pulmon Dis Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Int J Chron Obstruct Pulmon Dis Año: 2022 Tipo del documento: Article